6| Product Portfolio:

Novo Nordisk’s $NVO product portfolio spans a wide range of therapeutic areas. Here’s an overview of the company’s key products:

1⃣Diabetes Care:

🔸Insulin Products:
▫️NovoLog: Rapid-acting insulin used to control blood sugar levels after meals. 
▫️Levemir: Long-acting insulin that helps regulate blood sugar throughout the day and night. 
▫️Tresiba: Ultra-long-acting insulin providing stable blood sugar control over 24 hours or more. 
▫️Fiasp: Fast-acting insulin for immediate blood sugar control after meals.

🔸GLP-1 Receptor Agonists:
▫️Ozempic (Semaglutide): A once-weekly injection for type 2 diabetes that improves blood sugar control & helps with weight loss. 
▫️Victoza: A daily injection for type 2 diabetes that also aids in weight loss. 
▫️Rybelsus: The first oral GLP-1 receptor agonist for type 2 diabetes.